Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells
João Agostinho Machado‐Neto(Universidade de São Paulo), Fabı́ola Traina(Universidade de Ribeirão Preto)
Cited by 20
Related Papers
BCR‐ABL binds to IRS‐1 and IRS‐1 phosphorylation is inhibited by imatinib in K562 cells
|FEBS Letters|2002|39
Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms
|Cell Death and Disease|2018|30
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy
|Blood Cancer Journal|2022|29
Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms
|Scientific Reports|2019|22
Targeting glioma cells by antineoplastic activity of reversine
|Oncology Letters|2021|13